Progenitor International Research GmbH is a niche provider of drug development services in emerging market regions. Our specialized experience is focused on the value that these regions bring to our customers in terms of quality clinical programs conducted by some of the most experienced clinical staff in Asia, India, and South Africa. With over 800 ICH GCP experienced research professionals and a broad range of services, we provide a turn-key solution for emerging market needs.

Our combined corporate experience includes over 25 years commitment to drug development research. Regarding study experience, in the last 4-5 years, we have completed over 500 studies in the emerging markets. Our geographical coverage includes the following countries: Japan, China, Hong Kong, Singapore, Taiwan, Malaysia, Thailand, Korea, Australia, India, and South Africa.

We offer in-depth trial experience, relationships with key sites that are both key opinion leaders and good enrolling sites, and guidance on how to make your program in these regions a success. Additionally, we can support your full-service needs from preclinical through post marketing studies on a full- program or piece-by-piece basis as needed.